Trials / Completed
CompletedNCT01859702
Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to determine the moxifloxacin aqueous penetration when dosing with a combination drug Vigadexa preoperatively in cataract patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2013-05-22
- Last updated
- 2013-08-07
- Results posted
- 2013-08-07
Source: ClinicalTrials.gov record NCT01859702. Inclusion in this directory is not an endorsement.